Synergistically enhanced cancer immunotherapy by combining protamine-based nanovaccine with PD-L1 gene silence nanoparticle-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synergistically enhanced cancer immunotherapy by combining protamine-based nanovaccine with PD-L1 gene silence nanoparticle

Published:2023-07 Issue: Volume:242 Page:125223
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Jiang Mingxia,Chen Wenqiang,Sun Yanju,Zeng Jun,Ma Lina,Gong Jianping,Guan Xiuwen,Lu Keliang,Zhang Weifen

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference49 articles.

1. Delivery technologies for cancer immunotherapy;Riley;Nat. Rev. Drug Discov.,2019

2. Delivery strategies of cancer immunotherapy: recent advances and future perspectives;Zhao;J. Hematol. Oncol.,2019

3. A review of cancer immunotherapy toxicity;Kennedy;CA Cancer J. Clin.,2020

4. Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase;Guan;Biomaterials,2018

5. Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine;Noguchi;Cancer Immunol. Immunother.,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corrigendum to “Synergistically enhanced cancer immunotherapy by combining protamine-based nanovaccine with PD-L1 gene silence nanoparticle” [Int. J. Biol. Macromol. 242 (2023) 125223];International Journal of Biological Macromolecules;2024-10

2. Minimalist “in situ” tumor vaccine leveraging versatile dendrimer nanoplatform coordinated ICD and immunoagonist for boosted chemoimmunotherapy;Science China Materials;2024-06-14

3. The quest for nanoparticle-powered vaccines in cancer immunotherapy;Journal of Nanobiotechnology;2024-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3